Cinqair and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Cinqair (reslizumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Asthma.

The phase IV clinical study analyzes which people have Dizziness when taking Cinqair. It is created by eHealthMe based on reports of 530 people who have side effects when taking Cinqair from the FDA, and is updated regularly.

What is Cinqair?

Cinqair has active ingredients of reslizumab. eHealthMe is studying from 530 Cinqair users. Check the latest studies of Cinqair.

What is Dizziness?

Dizziness is found to be associated with 3,572 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

530 people reported to have side effects when taking Cinqair.
Among them, 19 people (3.58%) have Dizziness.

Among these 19 people:

How long have people been on Cinqair when they have Dizziness? *

What is the gender of people who have Dizziness when taking Cinqair? *

female: 73.68 %
male: 26.32 %

What is the age of people who have Dizziness when taking Cinqair? *

What are other drugs people take besides Cinqair? *

What are other side effects people have besides Dizziness? *

Dyspnea (difficult or laboured breathing): 8 people, 42.11%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 36.84%
Headache (pain in head): 6 people, 31.58%
Nausea (feeling of having an urge to vomit): 5 people, 26.32%
Fatigue (feeling of tiredness): 4 people, 21.05%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 15.79%
Skin - Clammy: 3 people, 15.79%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 15.79%
Feeling Abnormal: 3 people, 15.79%
Drug Ineffective: 3 people, 15.79%

What are the existing conditions these people have? *

Asthma: 9 people, 47.37%
Interstitial Lung Disease: 2 people, 10.53%
Immunodeficiency Common Variable: 2 people, 10.53%
Stress And Anxiety: 1 person, 5.26%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.26%
Hypersensitivity: 1 person, 5.26%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cinqair and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cinqair:

Cinqair (530 reports)

Dizziness treatments and more:

Dizziness (613,962 reports)

Browse all side effects of Cinqair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,572 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on reslizumab (the active ingredients of Cinqair) and Cinqair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.